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Background: The spread of MRSA strains at hospitals as well as in the community are of great concern worldwide.
We characterized the MRSA clones isolated at Tunisian hospitals and in the community by comparing them to
those isolated in other countries.
Results: We characterized 69 MRSA strains isolated from two Tunisian university hospitals between the years
2004-2008. Twenty-two of 28 (79%) community-associated MRSA (CA-MRSA) strains and 21 of 41 (51%)
healthcare-associated MRSA (HA-MRSA) strains were PVL-positive. The PVL-positive strains belonged to predicted
founder group (FG) 80 in MLST and carried either type IVc SCCmec or nontypeable SCCmec that harbours the class B
mec gene complex. In contrast, very diverse clones were identified in PVL-negative strains: three FGs (5, 15, and 22)
for HA-MRSA strains and four FGs (5, 15, 45, and 80) for CA-MRSA strains; and these strains carried the SCCmec
element of either type I, III, IVc or was nontypeable. The nucleotide sequencing of phi7401PVL lysogenized in a
CA-MRSA strain JCSC7401, revealed that the phage was highly homologous to phiSA2mw, with nucleotide identities
of more than 95%. Furthermore, all PVL positive strains were found to carry the same PVL phage, since these strains
were positive in two PCR studies, identifying gene linkage between lukS and mtp (major tail protein) and the
lysogeny region, both of which are in common with phi7401PVL and phiSa2mw.
Conclusions: Our experiments suggest that FG80 S. aureus strains have changed to be more virulent by acquiring
phi7401PVL, and to be resistant to β-lactams by acquiring SCCmec elements. These novel clones might have
disseminated in the Tunisian community as well as at the Tunisian hospitals by taking over existing MRSA clones.Background
The spread of antibiotic resistance among Staphylococcus
aureus strains is of great concern in the treatment of
Staphylococcal infections. Since the first Methicillin Re-
sistant Staphylococcus aureus (MRSA) strain was reported
in England in 1961 [1], MRSA has become one of the
most prevalent pathogens that cause nosocomial infec-
tions throughout the world. Recent reports suggest that it
has become increasingly prevalent in the community as
well since the 1990s [2-5]. In the 2000s, outbreaks of* Correspondence: teruybac@juntendo.ac.jp
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reproduction in any medium, provided the orcommunity-associated MRSA (CA-MRSA) strains were
observed worldwide as causative agents of community-
associated infections, e.g., superficial skin and soft tissue
infections, urinary tract infections and pneumonia [6-9].
Methicillin resistance in MRSA is encoded by the mecA
gene, which is carried by the SCCmec element, a mobile
genetic element that carries methicillin resistance [10,11].
The structures of SCCmec elements are divergent. At
least 11 types of SCCmec elements have been identified
[12-14]. Accordingly, MRSA clones are defined by the
combination of the genotype of the S. aureus strain and
the type of SCCmec [15]. By using molecular epidemio-
logical techniques, it became evident that CA-MRSA
strains were distinct from those of healthcare-associatedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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strains harbour small-sized type IV or type V SCCmec ele-
ments and are susceptible to many antibiotics [16-18]. In
contrast, HA-MRSA isolates carry one of the three types
of SCCmec (types I, II or III) or occasionally types IV and
V, and are generally multidrug resistant [6,19].
Interestingly, the majority of CA-MRSA strains that
have emerged worldwide carried the lukS-PV and lukF-PV
genes encoding Panton Valentine Leukocidine. Character-
istic PVL-positive MRSA clones have been disseminated
in each district or continent. In the United States, the
ST8-SCCmecIVa (USA300) clone and ST1-SCCmecIVa
(USA400) clone have been predominant. In Europe and
some Asian countries, the ST80-type IVa SCCmec and
ST59-SCCmecV(5C2&5) clones have been predominant,
respectively. The lukS-PV and lukF-PV genes are located
on bacteriophages. Since the first report of the PVL phage,
the nucleotide sequences of several PVL phages have
been reported [16,20-24]. Three structurally distinct
PVL phages belonging to groups 1-3, have been identi-
fied to date.
We characterized the MRSA clones disseminated in
Tunisian hospitals and the community. In this study, we
conducted a retrospective analysis of the HA-MRSA and
CA-MRSA strains isolated from two Tunisian hospitals
between the years of 2004 and 2008. In order to
characterize the MRSA strains, several different molecu-
lar typing methods were used: mecA gene PCR, SCCmec
typing, the carriage of PVL gene and the genotyping
using the agr locus typing, spa-typing and Multilocus
Sequences Typing (MLST). Furthermore, the nucleotide




The CA-MRSA strains were resistant to gentamicin (7%),
kanamycin (89%), amikacin (86%), tobramycin (18%), tet-
racyclines (75%), ofloxacine (11%), ciprofloxacin (36%),
erythromycin (46%), clindamycin (14%) and rifampicin
(4%). All strains were susceptible to pristinamycin, vanco-
mycin, teicoplanin, trimethoprime-sulfamethoxazole and
chloramphenicol. The HA-MRSA strains were resistant to
gentamicin (38%), kanamycin (90%), amikacin (90%),
tobramycin (26%), tetracyclines (88%), ofloxacine (30%),
ciprofloxacin (45%), erythromycin (55%), trimethoprim-
sulfamethoxazole (15%), chloramphenicol (7.5%), clinda-
mycin (18%), rifampicin (32%) and fosfomycine (10%). All
strains were sensitive to pristinamycin, vancomycin and
teicoplanin.
Characteristics of HA-MRSA clones
The characteristics of 41 HA-MRSA strains are summar-
ized in Table 1. Twenty-one strains were PVL positive,while 20 strains were PVL negative. All PVL-positive
strains belonged to the predicted founder group (FG,
formerly called the “clonal complex”) 80 in the MLST
genotype (ST80, 20 strains and ST1440, 1 strain). All
strains belonged to agr group III, and four spa-types (70,
346, 435, and new) were identified among them. All PVL-
positive strains carried the type IVc SCCmec element. In
contrast, the PVL-negative clones were very diverse. Eight
STs, three agr groups, and more than nine spa types were
identified (Table 1). These strains carried SCCmec ele-
ments of type I, III, IVc, or were nontypeable (NT). Ac-
cordingly, at least eight MRSA clones (ST247-SCCmecI,
ST1819-SCCmecI, ST239-SCCmecIII, ST241-SCCmecIII,
ST5-SCCmecIVc, ST1-SCCmecNT, ST22-SCCmecNT and
ST97-SCCmecNT) were identified in the 20 PVL-negative
HA-MRSA strains, whereas there were only two MRSA
clones, ST80-SCCmecIVc and ST1440-SCCmecIVc in
PVL-positive HA-MRSA strains.Characteristics of CA-MRSA strains
The characteristics of the 28 isolated CA-MRSA strains
are summarized in Table 1. Twenty-two strains (79%)
were PVL-positive and six strains (21%) were PVL-nega-
tive. All PVL-positive strains belonged to FG80 and agr
group III, and carried the type IVc or NT SCCmec elem-
ent similar to the cases of PVL-positive HA-MRSA
strains. Three spa-types (70, 346, and new) were identi-
fied among them. The PVL-negative strains belonged to
four FGs (5, 15, 45, and 80), three agr groups, I- III, and
there were more than four spa types (35, 381, 1021, and
new). These strains carried SCCmec elements of type IVc
or NT. As a result, five MRSA clones (ST1-SCCmecNT,
ST5-SCCmecI, ST5-SCCmecIVc, ST45-SCCmecNT and
ST80-SCCmecIVc) were identified in six PVL-negative
CA-MRSA strains.SCCmec elements identified in Tunisian MRSA
As listed in Table 1, the SCCmec type of 59 out of 69
MRSA strains were classified by one of the extant types.
All PVL-positive HA-MRSA strains and the majority of
CA-MRSA strains carried type IV SCCmec of subtype c.
Three PVL-positive CA-MRSA strains carried class B
mec, but no ccr genes were identified so far. We
expressed this as “NT-B”. SCCmecNT-B was identified
in three PVL-negative strains belonging to ST45 and
ST97. The SCCmec elements of the other four strains
were expressed as follows: NT-1 (type 1 ccr positive, the
class of the mec gene complex could not be determined),
NT-A (ccr genes were not identified, but it carried the
class A mec gene complex), NT-N (neither the ccr genes
nor the mec gene complex could be identified), and NT-
Bc (two ccr genes, types 1 and 2, were identified, and the
class B mec gene complex was identified).
Table 1 Characteristics of the MRSA clones isolated from Tunisian hospitals and the community
ST Predicted founder group (old clonal complex) agr type spa type SCC mec type
HA-MRSA (n=41)




ST1440(n=1) 80 III 70(n=1) IVc(n=1)
PVL-negative (n=20) ST1(n=1) 15(CC1) III 35(n=1) bNT-1(n=1)
ST5(n=3) 5(CC5) II 45(n=2) IVc(n=1)
NT-A(n=1)
335(n=1) IVc(n=1)
ST22(n=1) 22 II 998(n=1) NT-N(n=1)
ST97(n=2) 15 I 3(n=1) NT-B(n=1)
I new(n=1) NT-B(n=1)
ST239(n=4) 5(CC8) I 3(n=4) III(n=3)
ST241(n=3) 5(CC8) I 125(n=2) III(n=2)
4(n=1) III(n=1)
ST247(n=3) 5(CC8) I 40(n=3) I(n=3)
ST1819(n=3) 5(CC8) I new(n=3) I(n=3)
CA-MRSA(n=28)




ST153(n=2) 80 III new(n=1) NT-B(n=1)
70(n=1) IVc(n=1)
ST2563(n=1) 80 III 70(n=1) IVc(n=1)
PVL-negative(n=6) ST1(n=1) 15(CCI) III 35(n=1) NT-Bc(n=1)
ST5(n=2) 5 II 381(n=1) I(n=1)
1021(n=1) IVc(n=1)
ST45(n=1) 45 I aND(n=1) NT-B(n=1)
ST80(n=2) 80 II 1021(n=1) IVc(n=1)
III ND(n=1) IVc(n=1)
aND: could not be detected.
bNT: non typeable.
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We determined the nucleotide sequence of a PVL phage
lysogenized in a PVL-positive CA-MRSA strain, JCSC7401,
isolated in 2006. The strain belonged to ST80 and car-
ried nontypeable SCCmec (NT-B). This phi7401PVL was
45,334 bp in length from the rightmost phage attach-
ment site (attP-R) to the leftmost site (attP-L), in which
44 predicted ORFs larger than 99 bp were identified. The
core sequences of 29 nucleotides were located at both
ends of phi7401PVL. The G+C content of phi7401PVL
was 33.2%, and was comparable to other staphylococcalphages. The overall organization of phi7401PVL was the
same as that of previously-reported PVL phages, which
consisted of five regions relating to 1) lysogeny, 2) DNA
replication/transcriptional regulation, 3) structural mod-
ules (the packaging/head and tail), 4) the lysis module,
and 5) lukS-PV and lukF-PV (Figure 1a). The phage was
highly homologous to phiSa2mw, which belongs to
group 2 of sfi21-like Siphoviridae (Figure 1a and 1b).
The entire genome of the phage showed nucleotide
identity of more than 95% to that of phiSa2mw. Forty-




































Figure 1 a. Structural comparisons of the PVL phages. Structures of phi7401PVL and phiSa2mw are illustrated based on the nucleotide
sequences deposited in databases DDBJ/EMBL/GenBank under accession nos. BA000033 for phiSa2mw and AP012341 for phi7401PVL. Red
arrowhead indicates the location of attP. Black bars indicate the locus of amplified DNA fragments using 5 sets of primers. Green bars indicate
the locus of amplified DNA fragment identifying the carriage of gene linkages in phi7401PVL. ORFs are colored as follows: orange, ORFs related to
lysogeny; red, a ORF in DNA replication/recombination region with assigned functions; bright green, ORFs related to capsid formation; yellowish
orange, ORFs related to head formation; yellowish green, ORFs related to tail formation; blue, ORFs related to cell lysis; black, lukS-PV and lukF-PV.
The locations of the primers are indicated in lines flanked by arrow heads. Nucleotide sequences of the primers are listed in Additional file 2:
Table S2. b. Comparisons of the two phage genomes with a dot plot analysis. The genome sequence of phi7401PVL was compared to those of
phiPVL (group 1 cos-site Siphoviridae), phiSa2mw (group 2 cos-site Siphoviridae), and phiN315 (group 3 cos-site Siphoviridae) using a specialized
BLAST at NIBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Ordinate indicates the genome phi7401PVL. Abscissa indicates the genomes of three phages,
phiPVL, phiSa2mw, and phiN315, in dot plots A, B, and C, respectively.
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from 91-100% (Additional file 1: Table S1). The int
gene was truncated, although it was highly homologous
to extant PVL phages. Two ORFs, TUP03 encoding Na/K
ATPase and TUP16 encoding dUTPase, were less homolo-
gous to phiSa2mw.
In order to determine whether the Tunisian PVL positive
strains also carried the same PVL phage as phi7401PVL,
we conducted two PCR studies to identify the regions in
common with two PVL phages (phi7401PVL and phi-
SA2mw): a long range PCR study identifying gene linkage
lukS and the tail gene that can identify PVL phages of the
elongated head type and another PCR study identifying the
region related to lysogeny (Additional file 1: Table S1 and
Figure 1a). In our experiments, all the PVL positive strains
were positive in both PCR studies.Discussion
Antibiotic resistance to agents other than β-lactams
The majority of the HA-MRSA isolates were resistant to
kanamycin, amikacin and tetracycline. Although the
ratio was slightly low (25~55%), these strains were also
frequently resistant to tobramycin, gentamicin, erythro-
mycin, quinolones and rifampicin. Recently, it has been
reported that rifampicin resistance is related to glyco-
peptides resistance [25,26]. Since the ratio of rifampicin
resistant strains was relatively high, there is a possibility
that there might be glycopeptides related to low resist-
ance strains, e.g., hetero-VISA strains. However, glyco-
peptide resistance is beyond the focus of this study, so
we did not examine the details for these findings.
Similar to HA-MRSA isolates, the majority of CA-
MRSA isolates were resistant to kanamycin, amikacin
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tics, except for erythromycin and ciprofloxacin. These
data suggest that Tunisian CA-MRSA strains were more
resistant to kanamycin, tetracycline and erythromycin
than U.S. and Oceanian isolates [27]. In our study, only
four CA-MRSA strains were resistant to clindamycin,
thus suggesting that clindamycin can be used for the
treatment of CA-MRSA infections in Tunisia.
The PVL phage carried by Tunisian MRSA
The phi7401 carried by a ST80 Tunisian MRSA was
highly homologous to phiSa2mw carried by ST1-
SCCmecIVa MRSA. Only two ORFs, TUP03 and TUP16,
showed a lower identity to those of phiSa2mw. Interest-
ingly, TUP03 was identical to ORFs in phi12, phi13, and
the bacteriophage in MRSA strains JH1 and JH9, and
TUP16 was highly homologous to dUTPase in phiSLT
and phi108PVL, with nucleotide identities of 97%. These
data suggest that the components of phages were chimeric.
Numerous lysogenized phages were induced from the cells
of four strains, including JCSC7401 by mitomycin C induc-
tion. However, a hybridization experiment with a PVL
probe showed that no plaque of the PVL phase was
observed. This might have been due to the carriage of a
truncated int. It seems that lysogenization of the phage
occurred early to thus cause a mutation in the phage gen-
ome or that the ST80 strains might have an ability to cause
a mutation in the int to keep the inserted phage genome in
the chromosome in a stable form.
Characteristics of Tunisian MRSA
We determined MLST genotype of all 69 MRSA strains.
Our data clearly indicated that all PVL-positive MRSA
strains belonged to predicted founder group (FG) 80,
which was previously indicated as clonal complex (CC)
80 at the MLST website. In contrast, the PVL-negative
MRSA strains belonged to diverse FGs. In this study, we
used the FG, which is used at present in the eBurst
system on the MLST website. However, by using the old
CC system, we can distinguish some lineages more
clearly, e.g., ST239 that carries type III SCCmec as CC8
and ST5 that carries type II SCCmec as CC5, both of
which belonged to FG5. Therefore, we listed both the
present and former grouping systems in Table 1.
The agr types were well correlated with the MLST
genotypes; group I, STs 45, 97, 239, 241, 247, and 1819;
group II, STs 5 and 22; group III, STs 1, 80, 153, 1440,
and new. There was only one exceptional case of a ST80
strain belonging to the agr group II. Further experiments
including nucleotide sequence determination will be
needed to clarify this discrepancy.
The SCCmec types of the strains were further deter-
mined by multiplex PCR studies, leaving 10 strains still
nontypeable. The type IVc SCCmec was the mostrepresentative one in Tunisia. It was identified both in
CA-MRSA (79%) and HA-MRSA (56%). PVL-positive
MRSA strains carried SCCmec IVc and NT-B, which
was supposed to be a novel SCCmec type.
The characteristics of Tunisian MRSA strains were also
reported by Ben Nejma et al [28]. It has also been reported
that the CC80 CA-MRSA strains were predominant clones
in Tunisia, similar to many Europeans countries like
France, Belgium, and Switzerland [27,29]. The predomin-
ance of the type IVc SCCmec stain was also reported.
The majority of our CA-MRSA (79%) and HA-MRSA
(51%) isolates were pvl-positive and belonged to FG80.
Our study suggested that the PVL-positive MRSA strains
disseminated in Tunisia might be unique to Tunisia or
the surrounding countries. Although CC80 PVL positive
MRSA strains have been identified in European coun-
tries [30], the majority of them carried a type IVa
SCCmec element or their SCCmec subtype was not
determined. While two CA-MRSA isolates from Belgium
[29] were reported to belonged to ST153-MRSA-IV, the
report did not show its subtype.
According to previous studies, PVL-positive MRSA
isolates were reported to be associated with an agr group
III background [27,28,31]. Among our CA-MRSA iso-
lates, the most predominant agr group was group III,
followed by group II, then group I.
The PVL-positive MRSA clones disseminated in other
countries belonged to ST1, ST8, ST22, ST30 and
ST59, and carried distinct SCCmec elements. Recently,
ST30 has been associated with CA-MRSA strains in the
United States and in Ireland [27,31] and the ST93 and
ST772 strains have been reported in Australia and
India, respectively [32,33]. These data suggest that the
possibility of simultaneous co-evolution of CA-MRSA
organisms in different locations [27] is higher than the
possibility of dissemination of a single CA-MRSA clone
all over the world. PVL positive strains might therefore
have emerged elsewhere and spread in the community
and at hospitals.
It is interesting that the PVL-negative MRSA clones were
the same MRSA strains isolated in other countries. Two
other CA-MRSA isolates belonged to ST5-MRSA-IV
which is one of predominant clones in the Netherlands
[34]. Concerning the HA-MRSA, the agr group I was pre-
dominant, as reported previously in Tunisian MRSA [27].
The predominance of a group I background was also
reported in United States and in Korea [35,36]. Similar
results were obtained in European countries such as
Germany and Belgium [36]. Three isolates belonged to the
clone ST241-SCCmecIII. Two belonged to the ST247-
SCCmecI (Iberian) clone, which is one of predominant
clones in Poland [37]. Two other isolates belonged to
ST239-SCCmecIII (Hungarian) clone, which is predomin-
ant in Turkey [38].
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Tunisian PVL positive MRSA strains carried the PVL
phage, which was highly homologous to phiSa2mw, but
distinct in two ORFs. They belonged to FG80 and agr
group III, and carried type IVc or nontypeable SCCmec.
Such strains disseminated in the community and might
have spread at the Tunisian hospitals by taking over




One hundred and fifty-four non-replicated HA-MRSA
strains were isolated from 1999 through 2008 at Charles
Nicolle Hospital of Tunis. Among them, 41 strains iso-
lated from 2004 through 2008 were chosen based on
their resistance profiles. HA-MRSA strains were isolated
from mucous pus and blood cultures, puncture fluids,
urine, and biomaterials of inpatients.
A total of 28 non-replicated CA-MRSA strains were
isolated from January 2004 through June 2008 in two
Tunisian hospitals (Charles Nicolle Hospital and Habib
Bourguiba Hospital). CA-MRSA strains were isolated
from the specimens of the patients with MRSA infec-
tions who had not been recently (¬within the past year)
hospitalized or undergone a medical procedure (such as
dialysis, surgery, catheterization). The CA-MRSA strains
were generally recovered from mucous pus, puncture
fluids, urine and biomaterials from outpatients. Some
MRSA strains isolated from patients within 48 h of
hospitalization, e.g., after surgery, in the intensive care
unit, in the departments of nephrology, otorhinolaryn-
gology and gynecology, were also included.
Strain identification
The isolates were identified by the conventional methods
(Gram-positive cocci, catalase positive, mannitol fermenting
and DNase-positive) and were confirmed to be S. aureus by
their ability to coagulate rabbit plasma (bioMérieux, Marcy
l’Etoile, France) and to produce clumping factor (Staphy-
slide test, bioMérieux). The biotypes were determined using
Api20 Staph (bioMérieux, Marcy l’Etoile, France).
Isolation of MRSA strains
Strains were purified twice, first on MRSA BD select agar
(from Baird Dickinson) and then on the Difco Tryptic Soy
Agar (TSA) supplemented with an antimicrobial agent
(ceftizoxime sodium) from Astellas Pharma Inc, Tokyo,
Japan. The detection of the mecA gene by PCR was con-
ducted as described previously [39].
The MIC of oxacilline
The MIC of oxacilline was determined by the agar dilu-
tion method according to the Clinical and LaboratoryStandards Institute guidelines (CLSI) [40]. S. aureus
ATCC 29213 was used as a reference strain.
Antimicrobial susceptibility testing
The antibiotic susceptibility of the isolates was assessed
using the disk diffusion method according to the CLSI
guidelines, except for pristinamycine, which was used
according to the CA-SFM guidelines. The following
antimicrobial disks were tested: penicillin G (10UI),
oxacillin (1 μg), ampicillin (10 μg), amoxicillin + clavulanic
acid (20/10 μg), cephalotin (30 μg), cefoxitin (30 μg), kana-
mycin (30 μg), gentamicin (10 μg), tobramycin (10 μg),
tetracyclines (30 μg), chloramphenicol (30 μg), ofloxa-
cin (5 μg), ciprofloxacin (5 μg), trimethoprim + sulfa-
methoxazole (1.25/23.75 μg), erythromycin (15 μg),
clindamycin (2 μg), vancomycin (10 μg), teicoplanin
(30 μg), rifampicin (5 μg), fosfomycin (5 μg) and pristi-
namycine (15 μg).
Culture and DNA extraction
The strains were grown on TSB culture at 37°C over-
night with shaking. Genomic DNA used as a target for
PCR assays was extracted by using a Qiagene kit (QIAamp
DNA Mini Kit (250) QUIAGEN. Sciences - US) according
to the manufacturer’s instructions.
SCCmec typing
The SCCmec elements were typed using two multi-
plex PCR strategies (M-PCR1 and M-PCR2) which are
used for SCCmec typing assignment, M-PCR3 was
used for the J1 region difference-based subtyping, as
described previously [41]. The reference strains used
were as follows: NCTC10442(type I), N315(type II),
85/2082(type III), CA05(type IVa), 8/6-3P(type IVb),
and 81/108(type IVc).
Detection of the Panton-valentine leukocidin gene
The carriage of lukF-PV and lukS-PV genes encoding
PVL was examined by PCR as described previously [42].
agr typing
The presence of the accessory gene regulator, agr, was
determined by multiplex PCR amplifying the hypervari-
able domain of the agr locus, as described previously
[43]. PCR amplification was performed in a 50 μl reac-
tion mixture composed of 2U of Ex Taq (Takara Shuzo
Co., Ltd., Kyoto, Japan), 10 pmol of each primer, 0.2 mM
deoxynucleoside triphosphate mixture, 10 ng of chromo-
somal DNA, 1X reaction buffer (Takara Shuzo Co., Ltd.)
and H2O. Thermal cycling was set at 30 cycles (30s for
denaturation at 95°C, 1 min for annealing at 55°C, and
2 min elongation at 72°C) and was performed with a
Gene Amp PCR system 9600 (Perkin-Elmer, Wellesley,
Massachusetts).
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The genotypes were determined by Multilocus Sequence
Typing (MLST) according to the procedure used by
Enright et al [44]. The alleles of each locus were com-
pared, and sequence types (STs) were assigned based on
the S. aureus MLST database (http://saureus.mlst.net/).
Spa typing
The typing of the polymorphic region of the protein A
gene (spa) was performed as described previously [45].
Purified spa PCR products were sequenced, and short se-
quence repeats (SSRs) were assigned using the spa data-
base website (http://www.tools.egenomics.com/).
Determination of nucleotide sequences
Genomic DNA of strain JCSC7401 was extracted with
phenol/chloroform and the nucleotide sequences were
determined using a 454 genetic analyzer. PCR studies
were conducted to amplify the DNA fragment covering
the gap of the contigs obtained by the 454 genetic
analyzer. The nucleotide sequence of PCR products
amplified by long-range PCRs with primer’s pairs listed in
Additional file 2 were determined using an ABI sequencer.
The nucleotide sequence of phi7401PVL was deposited to
the DDBJ/EMBL/GenBank databases under accession no.
AP012341.
Additional files
Additional file 1: Table S1. ORFs in and around phi7401PVLand their
similarities to phiSa2mw.
Additional file 2: Table S2. List of primers used in this experiment.
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